Article Archives

Article

Dose Optimization: Getting it Right for Vulnerable Populations

By: Justin Hay & Frank Engler Pandemics amplify existing strengths and vulnerabilities—not only highlighting who…

Certara2023年5月22日

Article

The Impact of the Inflation Reduction Act on Biosimilar Uptake

In an interview with HCPLive, Maximilian Vargas, PhD, MBA, vice president of the United States…

Certara2023年5月8日

Article

FDA’s Project Optimus Guidance: Highlights and Tips for Success for Oncology Drug Developers

2023 guidance from FDA on dosages in oncology provides further context on expectations with Project…

Certara2023年5月3日

Article

Overcoming CMC challenges in cell and gene therapy: part II

Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven…

Certara2023年4月22日

Article

LABO: Data utilisation and data infrastructure in drug development: Data, Data, Data

Published: 2023年4月12日 This is the German article written by Dr. Fabian Rauscher, Scientific…

Certara2023年4月12日

Article

Using Quantitative Systems Pharmacology Modelling to Accelerate Drug Development

Model informed drug development (in silico modelling) continues to be a game changer in accelerating…

Certara2023年3月29日

Article

Model-Informed Drug Development (MIDD) – EMA’s Advancement

Modelling and simulation (M&S) plays a crucial role in drug development. It allows information from…

Certara2023年3月29日

Article

Advancing data discovery in the life sciences through artificial intelligence

Vyasa has developed deep-learning artificial intelligence solutions for organizations looking to solve the complex data…

Certara2023年3月2日

Article

希少疾患医薬品開発の加速に秀でる

By: Rajesh Krishna, PhD, FAAPS and Steve Sibley According to the National Institutes of Health,…

Certara2023年1月26日

Article

プロジェクト・オプティマス：How to Prepare for Success

For some time now, cancer drug developers have known “Project Optimus” and new dose optimization…

Certara2022年11月28日

Powered by Translations.com GlobalLink Web Software

記事

Dose Optimization: Getting it Right for Vulnerable Populations

The Impact of the Inflation Reduction Act on Biosimilar Uptake

FDA’s Project Optimus Guidance: Highlights and Tips for Success for Oncology Drug Developers

Overcoming CMC challenges in cell and gene therapy: part II

LABO: Data utilisation and data infrastructure in drug development: Data, Data, Data

Using Quantitative Systems Pharmacology Modelling to Accelerate Drug Development

Model-Informed Drug Development (MIDD) – EMA’s Advancement

Advancing data discovery in the life sciences through artificial intelligence

希少疾患医薬品開発の加速に秀でる

プロジェクト・オプティマス：How to Prepare for Success

メルマガ登録

クイックアクセス

ソリューション

お問合せ